96 related articles for article (PubMed ID: 1952571)
1. Leukotriene (LT) D4 is involved in antigen-induced asthma: a study with the LTD4 receptor antagonist, MK-571.
Rasmussen JB; Margolskee DJ; Eriksson LO; Williams VC; Andersson KE
Ann N Y Acad Sci; 1991; 629():436. PubMed ID: 1952571
[No Abstract] [Full Text] [Related]
2. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.
Manning PJ; Watson RM; Margolskee DJ; Williams VC; Schwartz JI; O'Byrne PM
N Engl J Med; 1990 Dec; 323(25):1736-9. PubMed ID: 2174121
[TBL] [Abstract][Full Text] [Related]
3. MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.
Kips JC; Joos GF; De Lepeleire I; Margolskee DJ; Buntinx A; Pauwels RA; Van der Straeten ME
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):617-21. PubMed ID: 1892302
[TBL] [Abstract][Full Text] [Related]
4. Effect of RG 12525, an oral leukotriene D4 antagonist, on the airway response to inhaled leukotriene D4 in subjects with mild asthma.
Wahedna I; Wisniewski AS; Tattersfield AE
Br J Clin Pharmacol; 1991 Oct; 32(4):512-5. PubMed ID: 1958449
[TBL] [Abstract][Full Text] [Related]
5. Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma.
Gaddy JN; Margolskee DJ; Bush RK; Williams VC; Busse WW
Am Rev Respir Dis; 1992 Aug; 146(2):358-63. PubMed ID: 1489125
[TBL] [Abstract][Full Text] [Related]
6. Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma.
Rasmussen JB; Eriksson LO; Margolskee DJ; Tagari P; Williams VC; Andersson KE
J Allergy Clin Immunol; 1992 Aug; 90(2):193-201. PubMed ID: 1323587
[TBL] [Abstract][Full Text] [Related]
7. Effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma.
Britton J; Hanley S; Tattersfield A
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1003-6. PubMed ID: 2960142
[No Abstract] [Full Text] [Related]
8. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.
Amirav I; Pawlowski N
N Engl J Med; 1991 May; 324(18):1288. PubMed ID: 1849613
[No Abstract] [Full Text] [Related]
9. Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.
Margolskee DJ
Ann N Y Acad Sci; 1991; 629():148-56. PubMed ID: 1659276
[No Abstract] [Full Text] [Related]
10. Acute bronchodilation with an intravenously administered leukotriene D4 antagonist, MK-679.
Impens N; Reiss TF; Teahan JA; Desmet M; Rossing TH; Shingo S; Zhang J; Schandevyl W; Verbesselt R; Dupont AG
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1442-6. PubMed ID: 8389106
[TBL] [Abstract][Full Text] [Related]
11. Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects.
Dahlén B; Margolskee DJ; Zetterström O; Dahlén SE
Thorax; 1993 Dec; 48(12):1205-10. PubMed ID: 8303624
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility of leukotriene D4 inhalation challenge in asthmatics. Effect of a novel leukotriene D4/E4-antagonist (SR 2640) on leukotriene D4-induced bronchoconstriction.
Frølund L; Madsen F; Nielsen J
Allergy; 1991 Jul; 46(5):355-61. PubMed ID: 1928658
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the production and action of leukotrienes by MK-571 and MK-886.
Ford-Hutchinson AW
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():9-16. PubMed ID: 1847788
[No Abstract] [Full Text] [Related]
14. Development of novel leukotriene--based anti-asthma drugs: MK-886 and MK-571.
Young RN
Agents Actions Suppl; 1991; 34():179-87. PubMed ID: 1793062
[TBL] [Abstract][Full Text] [Related]
15. The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma.
Britton JR; Hanley SP; Tattersfield AE
J Allergy Clin Immunol; 1987 May; 79(5):811-6. PubMed ID: 3571772
[TBL] [Abstract][Full Text] [Related]
16. Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat.
Denzlinger C; Grimberg M; Kapp A; Haberl C; Wilmanns W
Br J Pharmacol; 1991 Apr; 102(4):865-70. PubMed ID: 1855116
[TBL] [Abstract][Full Text] [Related]
17. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics.
Dahlén B; Kumlin M; Margolskee DJ; Larsson C; Blomqvist H; Williams VC; Zetterström O; Dahlén SE
Eur Respir J; 1993 Jul; 6(7):1018-26. PubMed ID: 8396534
[TBL] [Abstract][Full Text] [Related]
18. Effects of timolol, indomethacin, and MK-571 on bronchoconstriction to infused leukotriene D4 in guinea pigs.
Masson P; Jones TR
Can J Physiol Pharmacol; 1990 Jul; 68(7):783-90. PubMed ID: 2383794
[TBL] [Abstract][Full Text] [Related]
19. Role of leukotriene D4 in allergen-induced increases in airway smooth muscle in the rat.
Wang CG; Du T; Xu LJ; Martin JG
Am Rev Respir Dis; 1993 Aug; 148(2):413-7. PubMed ID: 8342905
[TBL] [Abstract][Full Text] [Related]
20. Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
Phillips GD; Rafferty P; Robinson C; Holgate ST
J Pharmacol Exp Ther; 1988 Aug; 246(2):732-8. PubMed ID: 3404455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
